Semaglutide

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5529 publications

Improvement of post-COVID-19 vaccination dysautonomia with GLP-1 receptor agonist.

Improvement of post-COVID-19 vaccination dysautonomia with GLP-1 receptor agonist.

Journal: Immunopharmacology and immunotoxicology

Published: September 07, 2026

Off-label semaglutide: A call for monitoring protocols in non-obese populations.

Off-label semaglutide: A call for monitoring protocols in non-obese populations.

Journal: JPMA. The Journal of the Pakistan Medical Association

Published: September 07, 2026

Ozempic and thin line between therapy and dependence.

Ozempic and thin line between therapy and dependence.

Journal: JPMA. The Journal of the Pakistan Medical Association

Published: September 07, 2026

Adjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review.

Adjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review.

Journal: Diabetes technology & therapeutics

Published: September 04, 2026

Recent Advances in Glucagon-Like Peptide-1 Receptor and Melanocortin-4 Receptor Agonists for the Treatment of Obesity and Type 2 Diabetes.

Recent Advances in Glucagon-Like Peptide-1 Receptor and Melanocortin-4 Receptor Agonists for the Treatment of Obesity and Type 2 Diabetes.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Published: September 04, 2026

(Un)intended consequences of mass-prescribing GLP-1s.

(Un)intended consequences of mass-prescribing GLP-1s.

Journal: Science (New York, N.Y.)

Published: September 03, 2026

Integrating the liver into the cardiovascular-kidney-metabolic syndrome: pathophysiology and therapeutic implications.

Integrating the liver into the cardiovascular-kidney-metabolic syndrome: pathophysiology and therapeutic implications.

Journal: Current opinion in nephrology and hypertension

Published: September 02, 2026

GLP-1 receptor agonist exposure and non-arteritic anterior ischaemic optic neuropathy: an illustrative case.

GLP-1 receptor agonist exposure and non-arteritic anterior ischaemic optic neuropathy: an illustrative case.

Journal: Clinical & experimental optometry

Published: September 01, 2026

Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review.

Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review.

Journal: Annals of internal medicine

Published: August 31, 2026

Efficacy of Subcutaneous Semaglutide Dose Escalation in Reducing Insulin in Patients With Type 2 Diabetes.

Efficacy of Subcutaneous Semaglutide Dose Escalation in Reducing Insulin in Patients With Type 2 Diabetes.

Journal: Federal practitioner : for the health care professionals of the VA, DoD, and PHS

Published: August 29, 2026

Discontinuation of Semaglutide Therapy for Obesity Management.

Discontinuation of Semaglutide Therapy for Obesity Management.

Journal: JAMA network open

Published: August 28, 2026

Out-of-Pocket Costs and Adherence to Semaglutide for Obesity Among Commercially Insured Adults.

Out-of-Pocket Costs and Adherence to Semaglutide for Obesity Among Commercially Insured Adults.

Journal: JAMA health forum

Published: August 28, 2026

Showing 1-12 of 5,529

Last Updated: 09/26/2026